ANAB - AnaptysBio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANAB is currently covered by 9 analysts with an average price target of $87.84. This is a potential upside of $23.03 (35.53%) from yesterday's end of day stock price of $64.81.

AnaptysBio's activity chart (see below) currently has 159 price targets and 136 ratings on display. The stock rating distribution of ANAB is 91.3% BUY and 8.7% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.56% with an average time for these price targets to be met of 391.35 days.

Highest price target for ANAB is $100, Lowest price target is $20, average price target is $71.5.

Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 05-Mar-2026. First documented stock forecast 21-Feb-2017.

Currently out of the existing stock ratings of ANAB, 21 are a BUY (91.3%), 2 are a HOLD (8.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Oct-2025

$79

$14.19 (21.89%)

$78

11 days ago
(05-Mar-2026)

1/6 (16.67%)

$26.17 (49.54%)

56

Buy Since 21-Feb-2024

$85

$20.19 (31.15%)

$56

11 days ago
(05-Mar-2026)

3/5 (60%)

$32.17 (60.89%)

365

Buy Since 04-Jun-2025

$66

$1.19 (1.84%)

$51

11 days ago
(05-Mar-2026)

12/14 (85.71%)

$13.17 (24.93%)

268

Buy Since 01-Nov-2022

$100

$35.19 (54.30%)

$90

4 months 11 days ago
(05-Nov-2025)

6/12 (50%)

$64 (177.78%)

461

Buy Since 10-May-2024

$70

$5.19 (8.01%)

$40

5 months 1 days ago
(15-Oct-2025)

13/19 (68.42%)

$35.71 (104.14%)

147

Show more analysts

Please expand the browser size to see the chart

What is ANAB (AnaptysBio) average time for price targets to be met?

On average it took 391.35 days on average for the stock forecasts to be realized with a an average price target met ratio 60.56

Which analyst has the current highest performing score on ANAB (AnaptysBio) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on ANAB (AnaptysBio)?

Derek Archila works at WELLS FARGO and has 2 price targets and 3 ratings on ANAB

Which analyst is the currently most bullish on ANAB (AnaptysBio)?

Konstantinos Aprilakis with highest potential upside - $88.19

Which analyst is the currently most reserved on ANAB (AnaptysBio)?

Biren Amin with lowest potential downside - -$52.81

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?